Important caveat: no human clinical trials have been completed yet
BPC-157 requires robust safety trials in humans first, then trials to determine the dose-response required to elicit meaningful therapeutic regenerative changes, followed by trials to establish the long term safety
Translational Relevance A special point confronts BPC 157 effectiveness with standard growth angiogenic factors, and their healing effects on the tendon, ligament, muscle, and bone lesions vs
TO B-12 OR NOT TO B-12
We ship to USA, UK, Canada, EU member states, and Australia with tracking and discreet unmarked outer packaging
Medications: acid-reflux drugs (PPIs) and some diabetes medications (such as metformin) can interfere with B12 absorption